Search Results - Hay, Charles RM

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO)

    Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO) by Wall, Caroline, Xiang, Hua, Palmer, Ben, Chalmers, Elizabeth, Chowdary, Pratima, Collins, Peter W., Fletcher, Simon, Hall, Georgina W., Hart, Daniel P., Mathias, Mary, Sartain, Paul, Shapiro, Susan, Stephensen, David, Talks, Kate, Hay, Charles R.M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    First-in-Human Dose-Finding Study of AAVhu37 Vector-Based Gene Therapy: BAY 2599023 Has Stable and Sustained Expression of FVIII over 2 Years

    First-in-Human Dose-Finding Study of AAVhu37 Vector-Based Gene Therapy: BAY 2599023 Has Stable and Sustained Expression of FVIII over 2 Years by Pipe, Steven W, Sheehan, John P, Coppens, Michiel, Eichler, Hermann, Linardi, Camila, Wiegmann, Sara, Hay, Charles RM, Lissitchkov, Toshko

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

    Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies by Volkers, Peter, Hanschmann, Kay‐Martin, Calvez, Thierry, Chambost, Hervé, Collins, Peter W., Demiguel, Virginie, Hart, Daniel P., Hay, Charles R.M., Goudemand, Jenny, Ljung, Rolf, Palmer, Ben P., Santagostino, Elena, van Hardeveld, Ella M., van den Berg, Marijke, Keller‐Stanislawski, Brigitte

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX)

    101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Trans... by Pipe, Steven, Stine, Kimo, Rajasekhar, Anita, Everington, Tamara, Poma, Allen, Crombez, Eric, Hay, Charles RM

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

    Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases E... by Federici, Augusto B, Badiee, Zahra, Baghaipour, Mohammad-Reza, Castaman, Giancarlo, Eshghi, Peyman, Goudemand, Jenny, Hay, Charles RM, Hoorfar, Hamid, Karimi, Mehran, Keikhaei, Bijan, Lassila, Riitta, Leebeek, Frank, Lopez Fernandez, Maria Fernanda, Marino, Renato, Peake, Ian, Parra Lòpez, Rafael, Peyvandi, Flora, Santoro, Cristina, Siboni, Simona Maria, Tosetto, Alberto, Trossaert, Marc, Eikenboom, Jeroen C.J.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies

    FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies by Fischer, K., Iorio, A., Hollingsworth, R., Makris, M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Aplasia cutis congenita and low molecular weight heparin

    Aplasia cutis congenita and low molecular weight heparin by Sharif, Saba, Hay, Charles R.M., Clayton‐Smith, Jill

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Accountant's Encyclopedia

    Accountant's Encyclopedia by Frumer, Samuel, Hay, Leon E., Mikesell, R. M., Pearson, David B., Pressler, Stanley, Seawell, L. Vann, Spencer, Charles H., Walden, Robert E.

    Published in The Accounting review
    Get full text
    Review
    Save to List
    Saved in:

Search Tools: